Azacitidine in the front-line treatment of therapy-related myeloid neoplasms: a multicenter case series.

@article{Minoia2015AzacitidineIT,
  title={Azacitidine in the front-line treatment of therapy-related myeloid neoplasms: a multicenter case series.},
  author={Carla Minoia and Nicola Sgherza and Giacomo Loseto and Giuseppina Greco and Caterina Buquicchio and Francesca Merchionne and Chandrakala Toldo and Ida Galise and Angela Melpignano and Giuseppe Tarantini and Vincenzo Pavone and Attilio Guarini},
  journal={Anticancer research},
  year={2015},
  volume={35 1},
  pages={461-6}
}
BACKGROUND/AIM A continued increase in the incidence of therapy-related myeloid neoplasms (t-MN) is expected due to the improvement of chemotherapeutic treatments for solid and haematological malignancies. The use of 5-azacytidine (AZA) is emerging in these patients. We, therefore, analyzed the outcome of patients with t-MN ineligible for intensive… CONTINUE READING